Skip to content

Characterization and Prediction of Atrial Fibrillation-caused Adverse Events After Hospital Discharge for Cardiac Surgery

Massachusetts-wide Study of the Incidence of ATrial Fibrillation and Stroke Occurring After Discharge From Cardiac Surgery (MATRICeS)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03466125
Acronym
MATRICeS
Enrollment
25000
Registered
2018-03-15
Start date
2018-01-01
Completion date
2024-12-31
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Death, Stroke, Acute

Brief summary

The purpose of the research is to identify the frequency and severity of adverse events related to atrial fibrillation that occur after discharge from hospital where the patient underwent cardiac surgery. The Specific Aims of the proposed study are to: 1. Identify the predictors of postoperative atrial fibrillation after discharge from hospital. 2. Identify the frequency of readmission to hospital, or other resource use such as Emergency Department or outpatient visit, for the treatment or prophylaxis of postoperative AF and consequent stroke or bleeding outcomes. 3. Identify the risks for stroke, death and other morbidity in patients after cardiac surgery and the effect of postoperative AF upon subsequent stroke or bleeding outcomes.

Interventions

PROCEDURECardiac surgery

Retrospective cohort study

Sponsors

Beth Israel Deaconess Medical Center
CollaboratorOTHER
Massachusetts General Hospital
CollaboratorOTHER
Baystate Medical Center
CollaboratorOTHER
Cape Cod Hospital
CollaboratorOTHER
Mount Auburn Hospital
CollaboratorOTHER
Memorial University Medical Center
CollaboratorOTHER
Tufts Medical Center
CollaboratorOTHER
St. Elizabeth's Medical Center
CollaboratorUNKNOWN
SouthCoast Medical Group
CollaboratorOTHER
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients who underwent cardiac surgery in Massachusetts between 2012 - 2016

Exclusion criteria

* surgical procedures that do not include coronary artery bypass graft surgery, aortic valve surgery or mitral valve surgery; * surgical procedures that include MAZE surgery, or pulmonary vein isolation, ventricular assist device, heart transplantation, congenital heart surgery, bacterial endocarditis, cardiac trauma, cardiac tumor, ventricular septal defect repair, left ventricular aneurysm repair, pulmonary thromboendarterectomy, sub-aortic stenosis resection or surgical ventricular restoration; * surgical procedures on patients that have undergone MAZE surgery, AF ablation procedures, pulmonary vein isolation or left atrial appendage resection or ablation (such as Watchman devices).

Design outcomes

Primary

MeasureTime frameDescription
Recurrent atrial fibrillationUp to six years after surgeryRecurrent atrial fibrillation
Acute ischemic strokeUp to six years after surgeryAcute ischemic stroke
MortalityUp to six years after surgeryMortality

Countries

United States

Contacts

Primary ContactJochen D Muehlschlegel, MD, MMSc
jmuehlschlegel@bwh.harvard.edu617-732-7330

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026